Literature DB >> 12113153

A cross-cultural comparison of family resiliency in hemodialysis patients.

Nancy White1, Judy Bichter, Jane Koeckeritz, Young A E Lee, Kristy L Munch.   

Abstract

The purpose of this descriptive comparative survey was to examine differences in family resiliency between hemodialysis patients and caregivers across three ethnically diverse samples that included Anglo-Americans, Mexican Americans, and South Koreans. The study was based on the Family Resiliency Model developed by McCubbin, Thompson, and McCubbin. The patients were in end-stage renal disease and were receiving hemodialysis treatments at either a freestanding hemodialysis unit or a 30-bed dialysis hospital unit. South Korean patients on hemodialysis and their caregivers perceived the stressors imposed by their illness to be significantly greater than either of the other ethnic groups, and they also scored lower on the resiliency measure than the other two groups. Findings of the study support the need to understand the dynamics of family resiliency from a cultural perspective.

Entities:  

Mesh:

Year:  2002        PMID: 12113153     DOI: 10.1177/10459602013003011

Source DB:  PubMed          Journal:  J Transcult Nurs        ISSN: 1043-6596            Impact factor:   1.959


  3 in total

1.  The impact of logistics and resilience on compliance.

Authors:  Jose Grünberg
Journal:  Pediatr Nephrol       Date:  2005-10-06       Impact factor: 3.714

2.  The effect of resilience on posttraumatic stress disorder in trauma-exposed inner-city primary care patients.

Authors:  Glenda L Wrenn; Aliza P Wingo; Renee Moore; Tiffany Pelletier; Alisa R Gutman; Bekh Bradley; Kerry J Ressler
Journal:  J Natl Med Assoc       Date:  2011-07       Impact factor: 1.798

3.  Family Resilience, Parenting Styles and Psychosocial Adjustment of Children With Chronic Illness: A Cross-Sectional Study.

Authors:  Yuan Qiu; Liuqing Xu; Yinzhu Pan; Chunlei He; Yingying Huang; Huan Xu; Zhongqiu Lu; Chaoqun Dong
Journal:  Front Psychiatry       Date:  2021-05-12       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.